The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at least the middle of the year.

Key Takeaways Merck shares fell sharply Tuesday morning after the drugmaker's profits and 2025 outlook fell short of estimates.Revenue and adjusted earnings, however, managed to top expectations.Sales of a few Merck drugs were hit by lower international demand and lower pricing in the U.